10um Streptavidin Magnetic Beads MSA10UM-10 1%

10µm Streptavidin Magnetic Beads MSA10UM-10

MSA10UM-10 is a 10µm streptavidin-functional magnetic bead suspension supplied at 1% solids.

When the solids concentration is expressed as weight per volume, 1% corresponds to approximately 10mg of magnetic beads per milliliter of suspension.

The product is developed for the capture and immobilization of biotinylated antibodies, antigens, proteins, peptides, aptamers, oligonucleotides and other biotin-labelled biomolecules.

MSA10UM-10 can be evaluated as a large-particle magnetic solid phase in immunoassay reagent development, chemiluminescence immunoassay research, target enrichment, sample pretreatment, affinity capture, process scale-up and batch reagent manufacturing.

Streptavidin immobilized on the magnetic bead surface binds biotinylated ligands without requiring the end user to activate the beads using EDC, NHS, glutaraldehyde or another chemical activation reagent.

After loading the selected biotinylated capture molecule, the functionalized magnetic beads can be used for target capture, magnetic collection, repeated washing and downstream signal detection.

MSA10UM-10 is intended for biotechnology companies, immunoassay developers, research institutions and reagent manufacturers requiring a defined 10µm streptavidin magnetic bead raw material for laboratory evaluation, pilot production and bulk supply.

Because 10µm is a relatively large particle size for an analytical magnetic bead, the finished reagent should be validated using the intended ligand, sample matrix, magnetic separator, mixing method, washing program, signal chemistry and analyzer.

Product Overview

The streptavidin–biotin system provides a flexible method for immobilizing different biotinylated biomolecules on a common magnetic solid phase.

Exact-10µm streptavidin magnetic bead products are commercially available at 1% solids and are used for biotin capture, detection assays, immunodiagnostic research, immunoprecipitation, nucleic acid purification and biological separation.

MSA10UM-10 is designed to support:

• Biotinylated antibody immobilization;

• Biotinylated antigen immobilization;

• Magnetic sandwich immunoassays;

• Antibody-detection assays;

• Competitive immunoassays;

• Chemiluminescence immunoassay development;

• Electrochemiluminescence assay research;

• Sample pretreatment;

• Immunomagnetic enrichment;

• Affinity capture;

• Biotinylated peptide capture;

• Nucleic acid and aptamer capture;

• Pilot-scale manufacturing;

• Batch production.

MSA10UM-10 is supplied as a research and reagent-development raw material. It is not supplied as a finished diagnostic reagent.

MSA10UM-10 Product Specifications

The following product-specific parameters should be confirmed through the applicable technical data sheet and lot-specific certificate of analysis:

• Particle-size distribution;

• Streptavidin loading;

• Streptavidin activity;

• Free biotin-binding capacity;

• Biotinylated antibody-loading capacity;

• Biotinylated oligonucleotide-loading capacity;

• Nonspecific binding;

• Magnetic collection performance;

• Suspension buffer;

• Blocking formulation;

• Preservative system;

• Storage conditions;

• Shelf life;

• Lot-release criteria.

Different commercial 10µm products use different particle matrices, magnetic material contents, streptavidin immobilization methods and capacity tests. Competitor values should therefore be used only for benchmarking and not as specifications for MSA10UM-10.

How Do Streptavidin Magnetic Beads Work?

Streptavidin immobilized on the magnetic bead surface provides high-affinity binding sites for biotin.

When a biotinylated antibody, antigen, protein, peptide or oligonucleotide is incubated with MSA10UM-10, the biotin group binds to streptavidin on the particle surface.

The resulting complex can be represented as:

Magnetic bead–streptavidin–biotin–ligand

The biotinylated ligand provides biological recognition of the target, while the magnetic bead provides a solid phase for collection, washing and reagent handling.

Streptavidin-coated magnetic particles are widely used as matrices for separating biotinylated proteins, immunoglobulins and nucleic acids.

Example Using a Biotinylated Capture Antibody

A magnetic sandwich immunoassay may include the following steps:

1. Prepare a biotinylated capture antibody.

2. Incubate the antibody with MSA10UM-10.

3. Allow the biotin groups to bind to surface streptavidin.

4. Magnetically collect the antibody-loaded beads.

5. Remove unbound antibody.

6. Resuspend the beads in the selected reagent formulation.

7. Incubate the beads with the sample.

8. Capture the target antigen.

9. Add a labelled detection antibody.

10. Magnetically collect and wash the immune complex.

11. Add or trigger the selected signal reagent.

12. Measure the analytical signal.

Example Using a Biotinylated Antigen

For an antibody-detection assay:

1. Prepare a biotinylated antigen.

2. Load the antigen onto MSA10UM-10.

3. Remove unbound antigen.

4. Incubate the antigen-loaded beads with the sample.

5. Capture target-specific antibodies.

6. Add a labelled secondary antibody.

7. Perform magnetic collection and washing.

8. Measure the resulting analytical signal.

Example Using a Biotinylated Oligonucleotide

A biotinylated oligonucleotide may be immobilized for:

• Nucleic acid capture;

• Hybridization assays;

• Aptamer-based detection;

• Target enrichment;

• Probe immobilization;

• Molecular diagnostic research;

• Pull-down experiments;

• Sample preparation before amplification.

The position and degree of biotinylation should be selected to preserve hybridization or target-recognition activity.

Key Features of MSA10UM-10

Defined 10µm Particle Size

MSA10UM-10 provides a defined 10µm particle format rather than a broad micrometer-scale range.

Particle size can influence:

• Particle number per unit mass;

• Available geometric surface area;

• Ligand accessibility;

• Gravity-driven settling;

• Magnetic collection;

• Collection-zone formation;

• Washing efficiency;

• Redispersion;

• Automated liquid handling.

Commercial exact-10µm streptavidin magnetic particles are available with controlled particle-size distribution, but individual products differ in their matrices and magnetic material contents.

Streptavidin-Functional Surface

The bead surface provides affinity-binding sites for biotinylated ligands.

Potential ligands include:

• Biotinylated monoclonal antibodies;

• Biotinylated polyclonal antibodies;

• Biotinylated recombinant antigens;

• Biotinylated natural proteins;

• Biotinylated peptides;

• Biotinylated enzymes;

• Biotinylated aptamers;

• Biotinylated DNA probes;

• Biotinylated RNA probes;

• Biotinylated haptens;

• Other biotin-labelled recognition molecules.

1% Solids Formulation

When expressed as w/v, a 1% solids suspension corresponds to approximately 10mg/mL.

Approximate bead-mass calculations are:

• 10µL contains approximately 0.1mg of beads;

• 50µL contains approximately 0.5mg of beads;

• 100µL contains approximately 1mg of beads;

• 500µL contains approximately 5mg of beads;

• 1mL contains approximately 10mg of beads.

These calculations should only be used after confirming that the stated 1% concentration is expressed as w/v.

Sigma-Aldrich and KBsphere both list exact-10µm streptavidin magnetic particles at 1% solids or 10mg/mL, making this a familiar starting concentration for competitive comparison and method development.

No Additional Bead Activation Required

A properly biotinylated ligand can normally be loaded without activating the magnetic bead surface using EDC/NHS or another covalent coupling reagent.

This can simplify assay development because multiple biotinylated capture molecules can be compared using the same bead platform.

Clearly Observable Magnetic Collection

Under a compatible magnetic field, larger micrometer-scale particles may form a clearly visible collection zone.

This can help researchers monitor:

• Whether magnetic collection is complete;

• Whether particles are lost during aspiration;

• Whether aggregation has occurred;

• Whether washing is consistent;

• Whether the collected particles are completely redispersed.

Actual magnetic collection depends on magnetic material content, magnet strength, bead concentration, vessel geometry, sample volume and liquid viscosity.

Research-to-Production Supply

MSA10UM-10 can support:

• Initial feasibility evaluation;

• Biotinylated ligand screening;

• Immunoassay optimization;

• Sample-pretreatment development;

• Automated-analyzer evaluation;

• Stability studies;

• Pilot manufacturing;

• Lot-consistency assessment;

• Bulk raw-material procurement.

Why Choose 10µm Streptavidin Magnetic Beads?

Exact 10µm Product Positioning

MSA10UM-10 is positioned for customers whose development project, raw-material specification or existing workflow requires a nominal 10µm streptavidin magnetic carrier.

Established suppliers offer exact-10µm streptavidin-coated magnetic particles, confirming that this is a recognized commercial format for biotin capture and separation applications.

Convenient Manual Observation

Compared with smaller magnetic beads, 10µm particles can be easier to observe during manual development.

This may simplify:

• Magnetic recovery assessment;

• Supernatant removal;

• Repeated washing;

• Aggregation inspection;

• Bead-loss troubleshooting;

• Redispersion evaluation.

Potential Use in Sample Pretreatment

Ligand-loaded MSA10UM-10 can be evaluated for capturing or enriching targets before downstream analysis.

Potential targets include:

• Proteins;

• Antigens;

• Antibodies;

• Cells;

• Microorganisms;

• Biological particles;

• Nucleic acids;

• Other affinity-recognized materials.

Commercial 10µm streptavidin systems are used in protein purification, immunoprecipitation, nucleic acid purification and cell or organelle isolation.

Practical Repeated Washing

MSA10UM-10 may be evaluated in workflows requiring:

• Repeatable magnetic recovery;

• Controlled supernatant removal;

• Low particle loss;

• Consistent washing;

• Complete redispersion;

• Defined residual liquid volume.

Important Surface-Area Tradeoff

For spherical particles with similar material and density, increasing particle diameter reduces the number of particles and geometric surface area available per unit mass.

A protocol developed using 1µm or 3µm beads should therefore not be transferred directly to 10µm beads without re-optimizing:

• Bead dosage;

• Ligand-to-bead ratio;

• Loading time;

• Mixing conditions;

• Sample-incubation time;

• Washing conditions;

• Final bead concentration.

Automation Requires Specific Validation

MSA10UM-10 may be evaluated for automated or semi-automated magnetic immunoassay equipment, but compatibility should not be assumed.

Thermo Fisher distinguishes between magnetic bead products suitable for automated platforms and products intended mainly for manual processing, demonstrating that automation compatibility depends on the particle system and instrument rather than magnetism alone.

Important analyzer parameters include:

• Reagent-reservoir mixing;

• Particle settling during standby;

• Pipette-tip internal diameter;

• Tubing dimensions;

• Bead-dispensing accuracy;

• Reaction-vessel geometry;

• Magnet position;

• Magnetic collection time;

• Aspiration height;

• Wash volume;

• Redispersion;

• Carryover;

• Risk of fluidic blockage.

10µm vs 5µm, 3µm and 1µm Streptavidin Beads

A nominal particle size should not be evaluated alone. Other important differences include:

• Particle-size distribution;

• Magnetic material content;

• Surface matrix;

• Streptavidin loading;

• Active biotin-binding capacity;

• Blocking formulation;

• Nonspecific binding;

• Suspension buffer;

• Bead aggregation;

• Functional assay performance.

The preferred product should be selected through side-by-side testing in the intended assay.

Applications in Immunoassay Reagent Development

MSA10UM-10 may be evaluated for:

• Magnetic sandwich immunoassays;

• Antibody-detection assays;

• Competitive immunoassays;

• Chemiluminescence immunoassay development;

• Electrochemiluminescence research;

• Immunomagnetic target enrichment;

• Sample pretreatment;

• Affinity capture;

• Immunoprecipitation research;

• Protein interaction studies;

• Biotinylated nucleic acid capture;

• Cell or microorganism separation.

The suitability of the 10µm particle format depends on the target, sample matrix, reaction vessel, magnetic separator and downstream detection system.

Applications in Chemiluminescence Immunoassays

Magnetic Sandwich Immunoassays

A biotinylated capture antibody can be loaded onto MSA10UM-10.

The antibody-loaded magnetic beads capture the target antigen from the sample. A labelled detection antibody then forms a sandwich immune complex.

After magnetic collection and washing, the detection label produces the chemiluminescent signal.

Important development variables include:

• Magnetic bead dosage;

• Capture-antibody loading;

• Degree of antibody biotinylation;

• Sample volume;

• Capture time;

• Detection-antibody concentration;

• Wash efficiency;

• Chemiluminescent substrate;

• Signal-to-background ratio.

Antibody-Detection Assays

A biotinylated antigen can be immobilized on MSA10UM-10 to capture target antibodies from research samples.

Potential applications include:

• Infectious-disease antibody research;

• Autoantibody research;

• Vaccine-response studies;

• Recombinant antigen evaluation;

• Antibody-response monitoring.

Competitive Immunoassays

Biotinylated antigens, haptens or small-molecule conjugates may be immobilized for competitive immunoassay development.

This format may be evaluated when the target analyte cannot support a conventional two-antibody sandwich structure.

Electrochemiluminescence Research

MSA10UM-10 may be evaluated in electrochemiluminescence immunoassay research.

Compatibility should be confirmed with:

• Magnetic positioning module;

• Electrode configuration;

• Electrochemiluminescent label;

• Reaction buffer;

• Reaction vessel;

• Fluidic path;

• Washing sequence;

• Signal-reading program.

Immunomagnetic Enrichment

Biotinylated affinity ligands loaded onto MSA10UM-10 can be evaluated for enrichment of:

• Proteins;

• Antigens;

• Cells;

• Microorganisms;

• Biological particles;

• Other affinity-recognized targets.

Nucleic Acid and Aptamer Capture

Biotinylated DNA, RNA or aptamer probes may be immobilized for:

• Hybridization assays;

• Nucleic acid enrichment;

• Target capture before amplification;

• Aptamer-based detection;

• Biosensor development;

• Molecular diagnostic research;

• DNA–protein interaction studies.

Streptavidin magnetic particles are established matrices for separating biotinylated proteins, immunoglobulins and nucleic acids.

Compatible Biotinylated Antibodies and Biomolecules

Biotinylated Antibodies

Important antibody variables include:

• Antibody purity;

• Antibody concentration;

• Biotinylation chemistry;

• Degree of biotinylation;

• Biotin position;

• Antibody aggregation;

• Retained antigen-binding activity;

• Original formulation buffer.

Excessive biotinylation may reduce antibody activity or create an unfavourable orientation after immobilization.

Insufficient biotinylation may reduce bead loading.

Biotinylated Antigens

Biotinylated antigens may be used for antibody-detection assays.

The developer should confirm that biotinylation does not modify or block a critical antigenic epitope.

Biotinylated Peptides

Potential applications include:

• Antibody screening;

• Epitope analysis;

• Competitive immunoassays;

• Protein-interaction research;

• Affinity capture.

Biotinylated Oligonucleotides

Biotin may be introduced at the 5′ end, 3′ end or another validated position.

The modification position should preserve hybridization, target recognition or aptamer activity after immobilization.

Biotinylated Proteins and Enzymes

Biotinylated recombinant proteins or enzymes may be evaluated for:

• Protein-interaction studies;

• Enzyme assays;

• Affinity enrichment;

• Biosensor development;

• Calibration-material preparation.

Recommended Biotinylated Ligand Loading Workflow

The following workflow is a general development framework. It is not a validated product-specific protocol.

Step 1: Characterize the Biotinylated Ligand

Record:

• Ligand identity;

• Molecular weight;

• Concentration;

• Purity;

• Original formulation;

• Biotinylation method;

• Estimated degree of biotinylation;

• Biological activity;

• Aggregation status;

• Stabilizing additives.

Step 2: Remove Excess Free Biotin

Free biotin or unreacted small biotinylated compounds can occupy available streptavidin-binding sites before the intended antibody, antigen or probe is loaded.

Spherotech recommends removing excess free biotinylated primers and optimizing bead quantity because molecular size and the biotinylation procedure affect practical binding capacity.

Potential purification methods include:

• Desalting;

• Dialysis;

• Size-exclusion chromatography;

• Ultrafiltration;

• HPLC or FPLC where appropriate;

• Another validated purification method.

Step 3: Fully Resuspend MSA10UM-10

Mix the original bead suspension until it is homogeneous before sampling.

Possible methods include:

• Gentle inversion;

• Roller mixing;

• End-over-end rotation;

• Controlled vortexing;

• Another validated mixing method.

Because 10µm particles may settle during storage and process holds, maintain suitable mixing when preparing multiple aliquots.

Avoid excessive foaming.

Step 4: Calculate the Required Bead Mass

Assuming a concentration of 10mg/mL:

Bead mass = suspension volume × 10mg/mL

Prepare multiple bead-dose groups rather than testing only one condition.

Step 5: Wash or Equilibrate the Beads

Collect the particles using a compatible magnetic separator.

Remove the original suspension medium when required and equilibrate the beads in a validated ligand-loading buffer.

Do not allow the magnetic beads to dry.

Step 6: Add the Biotinylated Ligand

Evaluate several ligand-to-bead ratios.

Possible experimental groups include:

• Low ligand loading;

• Medium ligand loading;

• High ligand loading;

• Different incubation times;

• Different temperatures;

• Different buffer formulations.

Step 7: Maintain Gentle Mixing

Use sufficient mixing to maintain uniform bead–ligand contact without damaging the biological ligand.

For 10µm beads, mixing should prevent uneven settling during ligand loading.

Step 8: Magnetically Collect the Loaded Beads

Standardize:

• Magnet type;

• Vessel;

• Reaction volume;

• Bead concentration;

• Collection time;

• Collection position;

• Residual liquid volume.

Step 9: Retain the Supernatant

Retain the post-loading supernatant when ligand-loading efficiency needs to be measured.

Step 10: Wash the Loaded Beads

Remove:

• Unbound biotinylated ligand;

• Residual free biotin;

• Unwanted formulation components;

• Other unbound materials.

Step 11: Resuspend in the Final Buffer

Potential formulation components include:

• Buffer;

• Salt;

• Protein stabilizer;

• Synthetic polymer;

• Surfactant;

• Preservative;

• Sugar or polyol;

• Blocking component.

Step 12: Evaluate Functional Performance

Recommended tests include:

• Ligand-loading efficiency;

• Target-capture capacity;

• Blank signal;

• Positive signal;

• Signal-to-background ratio;

• Magnetic recovery;

• Bead redispersion;

• Precision;

• Accelerated stability;

• Real-time stability.

How to Optimize MSA10UM-10 in an Immunoassay

Optimize Bead Dosage

Compare several bead quantities in the complete assay.

Too few beads may limit target capture.

Too many beads may increase:

• Reagent consumption;

• Blank signal;

• Nonspecific adsorption;

• Washing requirements;

• Residual bead interference;

• Instrument carryover.

Optimize Biotinylated Ligand Loading

Evaluate several amounts of biotinylated antibody or antigen per milligram of beads.

The highest ligand-loading condition is not necessarily the best analytical condition.

Excessive loading may cause:

• Steric crowding;

• Reduced target accessibility;

• Higher nonspecific binding;

• Reduced functional activity;

• Poorer storage stability.

Optimize the Degree of Biotinylation

Compare ligands with different biotinylation levels.

Evaluate:

• Bead-loading efficiency;

• Retained biological activity;

• Target-capture performance;

• Blank signal;

• Positive signal;

• Precision;

• Stability.

Optimize Mixing

Because 10µm particles can settle during incubation, evaluate:

• Continuous versus intermittent mixing;

• Rotation speed;

• Shaking speed;

• Mixing duration;

• Reaction-vessel geometry;

• Bead uniformity;

• Foam formation;

• Ligand stability.

Optimize Magnetic Separation

Evaluate:

• Magnet strength;

• Magnet position;

• Collection time;

• Reaction-vessel geometry;

• Bead concentration;

• Buffer viscosity;

• Residual liquid;

• Bead loss during aspiration.

Optimize Washing

Compare:

• Wash-buffer composition;

• Surfactant concentration;

• Wash volume;

• Number of wash cycles;

• Mixing during washing;

• Magnetic collection time;

• Residual wash volume.

Insufficient washing may increase assay background. Excessive washing may reduce bead recovery or affect sensitive assay components.

Optimize Blocking and Storage Formulation

Potential formulation variables include:

• Protein blockers;

• Synthetic blocking polymers;

• Nonionic surfactants;

• Ionic strength;

• Sugars;

• Polyols;

• Preservatives.

The final formulation should support particle dispersion, low background, streptavidin activity and ligand stability.

Optimize Automated Analyzer Parameters

For automated immunoassay development, evaluate:

• Reagent-reservoir mixing frequency;

• Bead settling during standby;

• Bead-dispensing accuracy;

• Tip and tubing dimensions;

• Incubation mixing;

• Magnetic collection time;

• Aspiration height;

• Wash cycles;

• Residual volume;

• Bead redispersion;

• Carryover;

• Fluidic blockage risk.

How to Evaluate Biotin-Binding Performance

Total Biotin-Binding Capacity

A labelled biotin reagent can be used to estimate available streptavidin-binding sites.

Commercial exact-10µm products report substantially different capacity values because they use different particles, test molecules, bead concentration bases and analytical methods.

MSA10UM-10 should therefore have its own validated test method and internal acceptance range.

Biotinylated Antibody Loading

Measure the antibody quantity before and after loading.

An approximate calculation is:

Loaded antibody = Initial antibody − Unbound antibody

Possible analytical methods include:

• UV absorbance;

• BCA assay;

• Bradford assay;

• Fluorescence measurement;

• ELISA;

• Another validated protein assay.

Functional Target-Capture Capacity

Chemical ligand loading does not prove that the antibody or antigen remains biologically active.

Functional testing should measure actual target capture under representative assay conditions.

Nonspecific Binding

Compare:

• Unloaded streptavidin beads;

• Ligand-loaded beads;

• Blocked beads;

• Negative samples;

• Positive samples;

• Representative interfering materials.

Magnetic Recovery

Measure bead recovery after repeated magnetic collection and washing.

Immunoassay Performance

Evaluate:

• Blank signal;

• Negative-sample signal;

• Low-positive signal;

• High-positive signal;

• Signal-to-background ratio;

• Precision;

• Recovery;

• Linearity;

• Specificity;

• Hook effect;

• Stability.

Quality Control for Research and Batch Production

Appearance and Dispersion

Inspect:

• Suspension appearance;

• Visible aggregation;

• Sedimentation behaviour;

• Homogeneity after mixing;

• Ease of redispersion;

• Stability during process holds.

Particle Size and Distribution

Confirm the nominal 10µm particle size using an appropriate validated method.

For batch manufacturing, monitor both average particle size and particle-size distribution.

Solids Content

Verify solids concentration because it affects:

• Bead-mass calculations;

• Ligand-loading calculations;

• Assay formulation;

• Filling accuracy;

• Production yield.

Streptavidin Activity

Use a standardized biotin-binding test to evaluate functional streptavidin activity on the bead surface.

Biotin-Binding Capacity

Establish a validated test method and internal acceptance range.

Competitor values should only be used as benchmarking information, not as specifications for MSA10UM-10.

Biotinylated Antibody Loading

Use a representative biotinylated antibody to evaluate practical ligand-loading performance.

Magnetic Collection Performance

Standardize:

• Magnet;

• Vessel;

• Sample volume;

• Buffer;

• Bead concentration;

• Temperature;

• Collection time.

Nonspecific Binding

Evaluate background using representative proteins, antibodies and sample matrices.

Functional Immunoassay Performance

Recommended tests include:

• Blank signal;

• Negative-sample signal;

• Positive-sample signal;

• Signal-to-background ratio;

• Analytical sensitivity;

• Precision;

• Recovery;

• Linearity;

• Specificity;

• Stability.

Lot-to-Lot Consistency

For routine manufacturing, establish acceptance ranges for:

• Particle size;

• Particle-size distribution;

• Solids content;

• Streptavidin activity;

• Biotin-binding capacity;

• Magnetic collection;

• Dispersion;

• Nonspecific binding;

• Functional immunoassay performance.

Final raw-material approval should be based on performance in the complete assay system.

Scale-Up and Bulk Supply for Immunoassay Manufacturers

Evaluation Stage

Evaluation samples can support screening of:

• Biotinylated capture antibodies;

• Biotinylated antigens;

• Bead dosage;

• Ligand-loading level;

• Blocking formulation;

• Magnetic separation;

• Target-capture efficiency;

• Assay sensitivity;

• Background signal.

Pilot-Scale Stage

Pilot quantities can support:

• Ligand-loading process confirmation;

• Reagent formulation;

• Analyzer compatibility testing;

• Stability studies;

• Filling-process evaluation;

• Initial lot-consistency testing.

Batch-Production Stage

Bulk-supply planning may include:

• Annual demand;

• Purchasing forecast;

• Packaging volume;

• Quality specifications;

• Technical documentation;

• Quality documentation;

• Reserved-lot requirements;

• Change-control expectations;

• Safety-stock planning.

Commercial exact-10µm products are offered in laboratory packages and series-based industrial supply formats, demonstrating that packaging scalability and quality documentation are important purchasing factors in this category.

Scale-Up Considerations

A laboratory ligand-loading procedure should not be scaled only by multiplying reagent volumes.

Revalidate:

• Vessel geometry;

• Mixing efficiency;

• Bead-suspension uniformity;

• Ligand-addition sequence;

• Incubation time;

• Temperature uniformity;

• Magnetic collection;

• Washing efficiency;

• Process hold time;

• Final filling uniformity.

Maintaining a homogeneous suspension during ligand loading, storage and filling is particularly important for 10µm beads.

Custom Streptavidin Magnetic Bead Services

SHBC can evaluate customized streptavidin magnetic bead requirements for biotechnology companies, research institutions and immunoassay manufacturers.

Potential customization options include:

• Alternative particle sizes;

• Customized solids content;

• Adjusted streptavidin loading;

• Customer-specific biotin-binding targets;

• Alternative blocking systems;

• Customized suspension buffer;

• Alternative preservative systems;

• Customer-specified pH;

• Special packaging volumes;

• Pilot-scale manufacturing;

• Bulk manufacturing;

• OEM packaging;

• Private-label services;

• Customer-specific quality testing.

Customization feasibility depends on the requested specifications, intended application, validation requirements and order quantity.

Storage and Handling Recommendations

Store MSA10UM-10 according to the product label, technical data sheet and lot-specific certificate of analysis.

General handling recommendations include:

• Mix thoroughly before sampling;

• Maintain suspension uniformity during dispensing;

• Use clean and calibrated equipment;

• Avoid allowing the magnetic beads to dry;

• Prevent microbial and chemical contamination;

• Avoid freezing unless specifically validated;

• Avoid unnecessary exposure to extreme temperatures;

• Confirm buffer compatibility before buffer exchange;

• Prevent contamination with free biotin;

• Record the product lot number;

• Evaluate ligand-loaded bead stability separately.

Spherotech recommends maintaining streptavidin particles in liquid, avoiding drying and freezing, and using a homogeneous suspension during handling. KBsphere also notes that micrometer-scale magnetic beads can settle during storage and should be mixed before use.

Frequently Asked Questions

What is MSA10UM-10?

MSA10UM-10 is a 10µm streptavidin-functional magnetic bead suspension supplied at 1% solids for capturing biotinylated biomolecules in immunoassay research, sample pretreatment and batch reagent manufacturing.

What does 1% solids mean?

When expressed as w/v, 1% solids corresponds to approximately 10mg of magnetic beads per milliliter of suspension.

Which molecules can MSA10UM-10 capture?

MSA10UM-10 can be evaluated for binding biotinylated antibodies, antigens, proteins, peptides, aptamers, DNA, RNA and other biotin-labelled molecules.

What is the binding principle?

Biotin on the selected ligand binds to streptavidin immobilized on the magnetic bead surface.

Does MSA10UM-10 require EDC or NHS activation?

No additional EDC/NHS bead activation is normally required for loading a properly biotinylated ligand.

Is a capture antibody included?

No. MSA10UM-10 is supplied as a streptavidin magnetic bead raw material. The customer selects and prepares the required biotinylated capture ligand.

Is the 1% suspension ready to use directly?

Not necessarily. The optimal working concentration depends on the ligand, target concentration, sample volume, assay format and analyzer.

Why choose a 10µm particle size?

The 10µm format may be evaluated when a project requires a larger magnetic solid phase, clearly observable magnetic collection, repeated washing, sample pretreatment or compatibility with an existing 10µm raw-material specification.

How do 10µm beads differ from 5µm beads?

Compared with 5µm particles of similar material, 10µm particles generally provide fewer individual beads and less geometric surface area per unit mass, while showing more pronounced settling and different magnetic collection behaviour.

How do 10µm beads differ from 1µm beads?

The 1µm format generally provides more particles and greater geometric surface area per unit mass. The 10µm format may provide easier visual observation but requires greater attention to settling, mixing and automated liquid handling.

Do 10µm magnetic beads settle?

Micrometer-scale magnetic particles may settle during storage, incubation and temporary process holds. The suspension should be mixed before sampling and maintained under suitable mixing during processing.

Can MSA10UM-10 be used for chemiluminescence immunoassays?

MSA10UM-10 can be evaluated as a magnetic solid phase in CLIA development. Compatibility with the complete reagent system and analyzer must be validated.

Can it be evaluated for electrochemiluminescence assays?

The product may be evaluated in ECL research. Compatibility with the electrode, magnetic positioning system, fluidic path and signal chemistry must be confirmed experimentally.

Can MSA10UM-10 be used with automated analyzers?

It may be evaluated for automated or semi-automated systems. Dispensing, mixing, magnetic collection, aspiration, washing, redispersion and fluidic-path compatibility must be validated on the specific analyzer.

How much biotinylated antibody should be loaded?

The optimal amount depends on the validated binding capacity, antibody molecular weight, degree of biotinylation and assay requirements. Several loading levels should be compared.

Does more antibody always improve sensitivity?

No. Excessive ligand loading may cause steric crowding, reduce target accessibility and increase nonspecific binding.

Can free biotin interfere with loading?

Yes. Free biotin can occupy available streptavidin-binding sites and reduce loading of the intended biotinylated antibody, antigen or probe.

How can ligand-loading efficiency be measured?

Compare the initial ligand quantity with the quantity remaining in the post-loading supernatant. Functional target-capture activity should also be measured.

Can non-biotinylated antibodies bind specifically?

Non-biotinylated antibodies are not expected to bind specifically through the streptavidin–biotin interaction. Observed binding may result from nonspecific adsorption.

How should MSA10UM-10 be mixed?

Mix using a validated method such as inversion, roller mixing, end-over-end rotation or controlled vortexing until the suspension is homogeneous.

What should be checked if magnetic collection is incomplete?

Check:

• Magnet strength;

• Collection time;

• Bead concentration;

• Buffer viscosity;

• Particle aggregation;

• Vessel geometry;

• Sample volume.

What should be checked if ligand loading is low?

Evaluate:

• Degree of biotinylation;

• Free biotin contamination;

• Ligand concentration;

• Bead quantity;

• Loading time;

• Buffer compatibility;

• Ligand aggregation.

What should be checked if assay background is high?

Evaluate:

• Blocking formulation;

• Bead dosage;

• Ligand-loading density;

• Wash efficiency;

• Sample matrix;

• Nonspecific adsorption;

• Detection-reagent concentration.

Is MSA10UM-10 a finished diagnostic reagent?

No. MSA10UM-10 is supplied as a raw material for research and reagent development. The customer is responsible for validating the finished reagent, production process and intended application.

Are evaluation samples available?

Evaluation samples can be discussed according to the intended application, biotinylated ligand and required testing quantity.

Is bulk supply available?

Pilot-scale and bulk supply can be arranged for qualified research, development and manufacturing projects.

Can the concentration, buffer or packaging be customized?

Customized solids content, streptavidin loading, suspension buffer, blocking system and packaging format may be evaluated according to project requirements.

Request a Sample or Bulk Quotation

Contact SHBC to request an evaluation sample, technical information or bulk quotation for MSA10UM-10 10µm Streptavidin Magnetic Beads.

Please provide:

• Intended immunoassay application;

• Biotinylated antibody, antigen or other ligand;

• Ligand molecular weight;

• Biotinylation method;

• Estimated degree of biotinylation;

• Sample matrix;

• Required evaluation quantity;

• Estimated pilot quantity;

• Expected annual demand;

• Preferred packaging volume;

• Required technical documents;

• Required quality documents;

• Target development schedule;

• Custom specification requirements.

SHBC supports streptavidin magnetic bead projects from early ligand-loading evaluation and immunoassay optimization to pilot production and bulk manufacturing.